Canada markets closed

Aurobindo Pharma Limited (AUROPHARMA.NS)

NSE - NSE Real Time Price. Currency in INR
Add to watchlist
1,241.10-2.10 (-0.17%)
At close: 03:30PM IST
Currency in INR
Earnings EstimateCurrent Qtr. (Sep 2021)Next Qtr. (Dec 2021)Current Year (2022)Next Year (2023)
No. of Analysts222525
Avg. Estimate1414.1755.7762.29
Low Estimate13.313.9447.749.1
High Estimate14.714.463.5269.28
Year Ago EPSN/AN/AN/A55.77
Revenue EstimateCurrent Qtr. (Sep 2021)Next Qtr. (Dec 2021)Current Year (2022)Next Year (2023)
No. of Analysts332625
Avg. Estimate61.7B63.62B250.11B271.28B
Low Estimate59.2B62.27B234.74B242.8B
High Estimate64.52B65.38B268.4B298.66B
Year Ago SalesN/AN/AN/A250.11B
Sales Growth (year/est)N/AN/AN/A8.50%
Earnings HistoryInvalid DateInvalid DateInvalid Date2021-06-30
EPS Est.N/AN/AN/A14.53
EPS ActualN/AN/AN/A13.14
DifferenceN/AN/AN/A-1.39
Surprise %N/AN/AN/A-9.60%
EPS TrendCurrent Qtr. (Sep 2021)Next Qtr. (Dec 2021)Current Year (2022)Next Year (2023)
Current Estimate1414.1755.7762.29
7 Days Ago0000
30 Days Ago0000
60 Days Ago0000
90 Days Ago0000
EPS RevisionsCurrent Qtr. (Sep 2021)Next Qtr. (Dec 2021)Current Year (2022)Next Year (2023)
Up Last 7 DaysN/AN/A1N/A
Up Last 30 DaysN/AN/A1N/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/A1
Growth EstimatesAUROPHARMA.NSIndustrySector(s)S&P 500
Current Qtr.N/AN/AN/AN/A
Next Qtr.N/AN/AN/AN/A
Current YearN/AN/AN/AN/A
Next Year11.70%N/AN/AN/A
Next 5 Years (per annum)11.30%N/AN/AN/A
Past 5 Years (per annum)8.19%N/AN/AN/A